Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.6.0.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2014
Accounting Policies [Abstract]      
Federally insured limit $ 250,000    
Cash balances in excess of federally insured limits 12,046,890 $ 27,947,323  
Threshold to exceed for capitalization of expenditures $ 1,000    
Impairment of unamortized patent costs   338,906  
Remaining life of license rights 15 years    
Amortization expense $ 1,124,644 1,138,631 $ 448,456
Research and development expenses $ 16,460,714 $ 8,777,519 $ 4,369,413
Vesting term 5 years    
Potentially dilutive (warrants and options) excluded from computation diluted loss per share 440,449 1,313,536 3,995,343
Deferred tax asset - carryforward operating losses $ 40,779,002 $ 20,746,188